Cadila Healthcare Shares Jump 5% After Group Firm Zydus Cadila Gets US FDA Approval

Shares of the drugmaker Cadila Healthcare gained about 5% on Thursday after Zydus Cadila received final approval from the US health regulator to market antipsychotic Ziprasidone Hydrochloride capsules in the American market. The stock of Cadial healthcare rose as much as 5.09% to the day’s high of Rs 486.5 on BSE. The Nifty Pharma index gained 1.29% at 8,727.4 points and was the biggest gainer today led by the upsurge in Cadila shares. Other pharma shares which also advanced today are Divi’s Lab (up 2.66%), Sun Pharma (up 2.18%), Lupin (up 1.74%), Aurobindo Pharma (up 1.29%) and Wockhardt Pharma (up 1.27%).
The company has received the final approval from the United States Food and Drug Administration (USFDA) to market Ziprasidone Hydrochloride capsules in strengths of 20 mg, 40 mg, 60 mg, and 80 mg, Zyudus Cadila said in a statement.For More Information Please Visit : www.paceresearchindia.com and Call : 8817774774